Corrigendum to “Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor”. J Pediatr. 2024 Jun 28; 274:114176
Titel:
Corrigendum to “Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor”. J Pediatr. 2024 Jun 28; 274:114176
Auteur:
Terlizzi, Vito Fevola, Cristina Presti, Santiago Castaldo, Alice Daccò, Valeria Claut, Laura Sepe, Angela Majo, Fabio Casciaro, Rosaria Esposito, Irene Vitullo, Pamela Salvi, Marta Troiani, Patrizia Ficili, Francesca Parisi, Giuseppe Fabio Pantano, Stefano Costa, Stefano Leonetti, Giuseppina Palladino, Nicola Taccetti, Giovanni Bonomi, Paolo Salvatore, Donatello